Cargando…

Noonan syndrome: rhGH treatment and PTPN11 mutation

OBJECTIVE: To analyze the clinical data and genetic characteristics of Noonan syndrome, both the effect and side effects of recombinant human growth hormone (rhGH) treatment. METHODS: We collected clinical data from 8 children with Noonan syndrome diagnosed from November 2017 to June 2021. The diagn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xian, Wu, Jiali, Yuan, Yi, Yang, Li, Yu, Lirong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Clinical Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655517/ https://www.ncbi.nlm.nih.gov/pubmed/37525886 http://dx.doi.org/10.1002/mgg3.2266

Ejemplares similares

Inside the Noonan “universe”: Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns
por: Stagi, Stefano, et al.
Publicado: (2022)

Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD
por: Blum, Werner F, et al.
Publicado: (2021)

The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review
por: Chen, Meiping, et al.
Publicado: (2021)

GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy
por: Savage, Martin O., et al.
Publicado: (2021)

Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance
por: Cianfarani, Stefano
Publicado: (2021)

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011)

KRAS Analysis in 34 Noonan Syndrome Patients without PTPN11 Mutation
por: Yamamoto, Kaoru, et al.
Publicado: (2007)

Corrigendum: Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
por: Felício, João Soares, et al.
Publicado: (2019)

Rapid detection by hydrops panel of Noonan syndrome with PTPN11 mutation (p.Thr73Ile) and persistent thrombocytopenia
por: Schönfeld, Mascha, et al.
Publicado: (2020)

Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2021)

A First Case Report of Subependymoma in PTPN11 Mutation-Associated Noonan Syndrome
por: Boonyawat, Boonchai, et al.
Publicado: (2019)

A PTPN11 mutation in a woman with Noonan syndrome and protein-losing enteropathy
por: Wang, Na, et al.
Publicado: (2020)

Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations
por: Athota, Jeevana Praharsha, et al.
Publicado: (2020)

Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH
por: Chen, Hong, et al.
Publicado: (2023)

The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty
por: Wang, Mengjie, et al.
Publicado: (2016)

Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
por: Jorge, Alexander A L, et al.
Publicado: (2022)

Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 Gene mutation
por: Kim, Yoo-Mi, et al.
Publicado: (2013)

Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy
por: Caiazza, Martina, et al.
Publicado: (2020)

PTPN11 c.853T>C (p.Phe285Leu) mutation in Noonan syndrome with chylothorax
por: Watanabe, Daisuke, et al.
Publicado: (2022)

SUN-250 Natural History of Growth in Patients with SHOX Gene Haploinsufficiency and Impact of Treatment with rhGH in Adult Height
por: Menezes De Andrade, Nathalia, et al.
Publicado: (2019)

The Fetal Phenotype of Noonan Syndrome Caused by Severe, Cancer-Related PTPN11 Variants
por: Malniece, Ieva, et al.
Publicado: (2020)

Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation
por: Tornese, Gianluca, et al.
Publicado: (2019)

Ten years with biosimilar rhGH in clinical practice in Sweden – experience from the prospective PATRO children and adult studies
por: Lundberg, Elena, et al.
Publicado: (2020)

In silico and in vitro analysis of a rational mutation in gIII signal peptide and its effects on periplasmic expression of rhGH in E. coli
por: Ghasemi, Fahimeh, et al.
Publicado: (2022)

Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls
por: Slattery, Meghan, et al.
Publicado: (2014)

mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)
por: Ghasemi, Rohollah, et al.
Publicado: (2018)

Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study
por: Soliman, Ashraf T, et al.
Publicado: (2019)

GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021)

Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11)
por: Qiu, Wei, et al.
Publicado: (2014)

Tegumentary manifestations of Noonan and Noonan-related syndromes
por: Quaio, Caio Robledo D'Angioli Costa, et al.
Publicado: (2013)

Author Correction: mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)
por: Ghasemi, Rohollah, et al.
Publicado: (2019)

Response to Treatment with Recombinant Human Growth Hormone (rhGH) of Short Stature Children Born Too Small for Gestational Age (SGA) in Selected Centres in Poland
por: Glińska, Marta, et al.
Publicado: (2022)

Effect of the parental origin of the X-chromosome on the clinical features, associated complications, the two-year-response to growth hormone (rhGH) and the biochemical profile in patients with turner syndrome
por: Álvarez-Nava, Francisco, et al.
Publicado: (2013)

An Approach to the Design of a Particulate System for Oral Protein Delivery .II. Preparation and Stability Study of rhGH-Loaded Microspheres in Simulated Gastrointestinal Fluids
por: Nafissi Varcheh, Nastaran, et al.
Publicado: (2011)

Phase 2 Randomized, Placebo-Controlled Clinical Trial of Recombinant Human Growth Hormone (rhGH) During Rehabilitation From Traumatic Brain Injury
por: Dubiel, Rosemary, et al.
Publicado: (2018)

Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: Li, Juan, et al.
Publicado: (2021)

Recombinant human growth hormone (rhGH) treatment of MKN-45 xenograft mice improves nutrition status and strengthens immune function without promoting tumor growth
por: Wei, Lianping, et al.
Publicado: (2019)

Retracted: Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1vksqf0vlbj4rrsi0t77so1oje